Login / Signup

Minimal change disease with thrombotic microangiopathy following the Pfizer-BioNTech COVID-19 vaccine.

Fumika TanakaKan KatayamaKensuke JohKayo TsujimotoMasahiro YamawakiRyosuke SaikiTairo KuritaTomohiro MurataKaoru Dohi
Published in: Clinical kidney journal (2021)
Keyphrases
  • coronavirus disease
  • sars cov
  • respiratory syndrome coronavirus